What Happens After Hereditary Genetic Testing? Key Facts

You gave a blood or saliva sample, waited a few weeks, and now you are holding a result that says you carry a gene variant linked to disease. Or maybe the result came back negative and you expected to feel relieved, but you don’t. Either way, the report is not the end of the process. It is the beginning of a set of decisions that most people are not prepared to make alone.

After hereditary genetic testing, the next steps usually involve confirming the result with a certified genetics professional, understanding what the variant does and does not predict, and working through screening or prevention options that fit your actual risk. A positive result does not mean you will develop the disease. A negative result does not always mean you are in the clear. And a “variant of uncertain significance” means exactly what it says — the lab found something, but nobody can yet say what it means for your health.

What Happens After Hereditary Genetic Testing: The First Steps

The first thing to do is confirm that the test was clinically valid. Not all genetic tests are equal. Some are ordered by a doctor through a clinical laboratory and come with a detailed report. Others are sold directly to consumers and may look at only a small number of variants, or may report raw data without clinical interpretation. If your test came from a direct-to-consumer kit, the result generally needs to be confirmed in a clinical lab before it can guide medical decisions. Many clinicians will not act on a consumer kit result alone.

Next, you need a genetics professional to interpret the result in context. That usually means a genetic counselor or a medical geneticist. These are trained specialists, and their job is not just to read the report to you. It is to explain what the result means for you specifically, given your family history, your age, and your other risk factors.

A few things a genetics professional will typically walk through:

• Whether the variant is classified as pathogenic (disease-causing), likely pathogenic, uncertain, likely benign, or benign
• What the evidence base is for that classification
• What the result means for your personal risk, not the average person’s risk
• Which family members could also carry the variant, and how they could be tested
• What screening or risk-reduction options exist, and what the evidence says about each

This conversation usually takes 30 to 60 minutes and is often the single most useful part of the entire process. The report itself is a technical document. The counseling session is where it becomes usable information.

What Does a Positive Result Actually Mean?

A positive result means you carry a genetic variant that is associated with increased risk of a specific condition. It does not mean you have the condition, and it does not mean you will definitely develop it.

This distinction matters more than almost anything else in genetic testing. Genes are not destiny. Most common diseases — including most cancers, heart disease, and type 2 diabetes — result from a combination of many genes and many environmental and lifestyle factors. Even in hereditary conditions driven by a single gene, the same variant can produce very different outcomes in different people. This is called reduced penetrance, and it is the rule rather than the exception.

Take BRCA1 and BRCA2 variants as an example. These are among the most studied hereditary cancer variants. Carrying a pathogenic BRCA1 or BRCA2 variant substantially raises lifetime risk of breast and ovarian cancer. But the risk is not 100%, and it varies by which gene is affected, where the variant sits in the gene, and other factors. A positive result is a piece of information that changes the risk conversation. It does not deliver a verdict.

For some conditions, a positive result leads to clear, well-established screening protocols. For others, the guidance is less certain and depends on the specific gene and variant. This is one reason the counseling step matters — the meaning of “positive” varies enormously depending on what was tested.

What About a Negative Result?

A negative result is only as good as the test that produced it. If you were tested because a family member has a known pathogenic variant, and the lab specifically looked for that variant and did not find it, then a negative result is genuinely meaningful. It usually means you did not inherit that family risk.

But if you were tested without a known family variant to target, a negative result is much less informative. Most tests only look at a subset of genes or variants. A negative result may simply mean the test did not cover the variant you carry. It does not rule out a hereditary cause.

This is one of the most common misunderstandings in genetic testing. People hear “negative” and assume they are clear. In many cases, the honest interpretation is “no pathogenic variant was found in the genes we looked at.” That is a different statement.

What Is a Variant of Uncertain Significance?

A variant of uncertain significance, often shortened to VUS, means the lab found a change in your DNA but does not have enough evidence to say whether it causes disease. These results are common, and they are frustrating.

The correct response to a VUS is usually to do nothing based on that result alone. Clinical guidelines generally advise against using a VUS to make medical decisions, because acting on uncertain information can lead to unnecessary procedures or surgeries. Over time, as more data accumulates, many VUS results get reclassified — some as benign, some as pathogenic. That is why it matters to stay in contact with the lab or clinic that issued the report, so you can be notified if the classification changes.

If you receive a VUS, ask your genetics professional two questions: does this change my screening compared to the general population, and how will I be told if the classification changes? The answers should guide what you do next.

How Do Results Affect Family Members?

Hereditary genetic results are rarely just about you. If you carry a pathogenic variant, your biological relatives may also carry it. Whether they should be tested depends on the inheritance pattern of the condition and your family structure.

For conditions inherited in an autosomal dominant pattern — Huntington’s disease and hereditary breast and ovarian cancer syndromes are common examples — each first-degree relative has a 50% chance of carrying the same variant. That is a coin flip, not a certainty, and it works in both directions. Some siblings will carry it, some will not.

Telling family members is often the hardest part of the process. There is no perfect script, and some people choose not to share. But relatives cannot make informed decisions about their own screening if they do not know the information exists. Many genetics clinics can provide a family letter — a document you can share that explains the finding without requiring you to explain the science yourself.

What Screening and Prevention Options Come Next?

What happens next depends entirely on the condition and the gene involved. There is no single protocol. For some hereditary cancer syndromes, established guidelines recommend earlier and more frequent screening — for example, starting mammography or MRI at a younger age than the general population. For others, risk-reducing surgery is an option that some people choose and others do not.

These are genuinely difficult decisions, and the evidence does not always point clearly in one direction. Risk-reducing surgery can substantially lower cancer risk for certain high-penetrance variants, but it also has real consequences and is irreversible. Enhanced screening catches some cancers earlier but does not prevent them. Which path is right depends on the specific variant, your age, your other health factors, and what matters to you.

What is well established is that these decisions benefit from specialist input. A general practitioner may not have current knowledge of the guidelines for a rare hereditary syndrome. A specialist — an oncologist, cardiologist, or other clinician familiar with the specific condition — usually does.

Does Genetic Testing Affect Insurance or Employment?

In the United States, the Genetic Information Nondiscrimination Act, known as GINA, prohibits health insurers and employers from discriminating based on genetic information. That protection is real and it matters.

But GINA has limits that people often do not know about. It does not cover life insurance, disability insurance, or long-term care insurance. Those insurers can, in many states, ask about genetic test results and use them in underwriting decisions. This is a genuine consideration for anyone deciding whether and when to test, and it is worth discussing with a genetics counselor before testing, not after.

State laws vary, and some offer broader protections than federal law. The details are worth checking for your specific state if this is a concern.

What If You Feel Overwhelmed by the Result?

That reaction is common and it is not a sign that something is wrong with you. Genetic results can feel like they change your identity, your plans, and your sense of what the future holds. Even a result that turns out to be manageable can trigger anxiety, grief, or a sense of isolation.

Genetic counselors are trained to address this, and many clinics offer follow-up support beyond the initial session. Some people find it helpful to connect with others who carry the same variant, though the quality of those communities varies. If anxiety or low mood persists for weeks, talking to a mental health professional who understands medical uncertainty is reasonable. There is no clinical evidence that any particular coping strategy works better than another here — what helps is individual.